Research ArticleBrain
Erdheim-Chester Disease of the Central Nervous System: New Manifestations of a Rare Disease
P. Sedrak, L. Ketonen, P. Hou, N. Guha-Thakurta, M.D. Williams, R. Kurzrock and J.M. Debnam
American Journal of Neuroradiology December 2011, 32 (11) 2126-2131; DOI: https://doi.org/10.3174/ajnr.A2707
P. Sedrak
aFrom the Section of Neuroradiology (P.S., L.K., N.G.-T., J.M.D.)
L. Ketonen
aFrom the Section of Neuroradiology (P.S., L.K., N.G.-T., J.M.D.)
P. Hou
bDepartments of Radiology, Physics (P.H.)
N. Guha-Thakurta
aFrom the Section of Neuroradiology (P.S., L.K., N.G.-T., J.M.D.)
M.D. Williams
cPathology (M.D.W.)
R. Kurzrock
dInvestigational Cancer Therapeutics (R.K.), University of Texas MD Anderson Cancer Center, Houston, Texas.
J.M. Debnam
aFrom the Section of Neuroradiology (P.S., L.K., N.G.-T., J.M.D.)

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Advertisement
P. Sedrak, L. Ketonen, P. Hou, N. Guha-Thakurta, M.D. Williams, R. Kurzrock, J.M. Debnam
Erdheim-Chester Disease of the Central Nervous System: New Manifestations of a Rare Disease
American Journal of Neuroradiology Dec 2011, 32 (11) 2126-2131; DOI: 10.3174/ajnr.A2707
Jump to section
Related Articles
- No related articles found.
Cited By...
- Neuroimaging Spectrum of Erdheim-Chester Disease: An Image-Based Review
- Erdheim-Chester Disease
- Erdheim-Chester Disease
- Central nervous system involvement in Erdheim-Chester disease: An observational cohort study
- Vemurafenib as first-line therapy in BRAF-V600E-mutant Erdheim-Chester disease with CNS involvement
- Neuroradiologic manifestations of Erdheim-Chester disease
- Complete remission of critical neurohistiocytosis by vemurafenib
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
More in this TOC Section
Similar Articles
Advertisement